Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
申请人:Merck Patent GmbH
公开号:US10005784B2
公开(公告)日:2018-06-26
The present invention relates to pyridine, pyrimidine, and pyrazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
PYRIDINES, PYRIMIDINES, AND PYRAZINES, AS BTK INHIBITORS AND USES THEREOF
申请人:Merck Patent GmbH
公开号:US20170226113A1
公开(公告)日:2017-08-10
The present invention relates to pyridine, pyrimidine, and pyrazene compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.